Data gathered: January 22
AI Stock Analysis - Aura Biosciences (AURA)
Analysis generated April 17, 2024. Powered by Chat GPT.
Aura Biosciences is a biotech company at the forefront of fighting cancer through the development of novel targeted therapies. Their commitment to innovation and patient care has differentiated them as a leader in their niche. Offering a valuable pipeline of therapeutics, Aura Biosciences is focused on addressing unmet needs in oncology, with a particular emphasis on ocular melanoma. By employing advanced technology and groundbreaking research, Aura Biosciences aims to deliver products that improve patient outcomes significantly.
Stock Alerts - Aura Biosciences (AURA)
 |
Aura Biosciences | January 22 Insider Alert: de los Pinos Elisabet is selling shares |
|
Aura Biosciences | December 18 Price is down by -6.1% in the last 24h. |
|
Aura Biosciences | December 16 Price is up by 5.8% in the last 24h. |
|
Aura Biosciences | December 6 Price is up by 7.1% in the last 24h. |
Alternative Data for Aura Biosciences
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 3 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 2,000 | Sign up | Sign up | Sign up |
| Employee Rating | 84 | Sign up | Sign up | Sign up |
| Google Trends | 60 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 162 | Sign up | Sign up | Sign up |
| Twitter Followers | 589 | Sign up | Sign up | Sign up |
| Twitter Mentions | 1,446 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 73 | Sign up | Sign up | Sign up |
| Linkedin Employees | 113 | Sign up | Sign up | Sign up |
About Aura Biosciences
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer.
| Price | $7.93 |
| Target Price | Sign up |
| Volume | 109,430 |
| Market Cap | $388M |
| Year Range | $6.81 - $11.74 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
 |
PharmaCyte Biotech (OTCMKTS:PMCBD) and Aura Biosciences (NASDAQ:AURA) Head to Head ComparisonJanuary 18 - ETF Daily News |
 |
Barclays PLC Buys 43,897 Shares of Aura Biosciences, Inc. (NASDAQ:AURA)January 3 - ETF Daily News |
|
Aura Biosciences, Inc. (NASDAQ:AURA) Given Consensus Recommendation of “Buy” by BrokeragesJanuary 1 - ETF Daily News |
|
Wellington Management Group LLP Purchases New Holdings in Aura Biosciences, Inc. (NASDAQ:AURA)December 20 - ETF Daily News |
|
Charles Schwab Investment Management Inc. Has $1.23 Million Stock Position in Aura Biosciences, Inc. (NASDAQ:AURA)December 18 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 2.3M | 6.2M | -3.9M | -21M | -23M | -0.420 |
| Q2 '24 | 2.5M | 5.9M | -3.4M | -20M | -22M | -0.410 |
| Q1 '24 | 2.7M | 5.3M | -2.6M | -20M | -22M | -0.400 |
| Q4 '23 | 2.4M | 4.5M | -2.1M | -22M | -24M | -0.560 |
| Q3 '23 | 2M | 5.1M | -3.1M | -19M | -19M | -0.480 |
Insider Transactions View All
| Hopkins Janet Jill filed to sell 151,693 shares at $9.4. November 18 '24 |
| Elazzouzi Amy filed to sell 39,443 shares at $10.7. October 29 '24 |
| De Los Pinos Elisabet filed to sell 320,647 shares at $10.7. October 29 '24 |
| De Los Pinos Elisabet filed to sell 329,847 shares at $12. October 18 '24 |
| Feder Julie B filed to sell 134,276 shares at $12. October 21 '24 |
Similar companies
Read more about Aura Biosciences (AURA) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Aura Biosciences?
The Market Cap of Aura Biosciences is $388M.
What is the current stock price of Aura Biosciences?
Currently, the price of one share of Aura Biosciences stock is $7.93.
How can I analyze the AURA stock price chart for investment decisions?
The AURA stock price chart above provides a comprehensive visual representation of Aura Biosciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Aura Biosciences shares. Our platform offers an up-to-date AURA stock price chart, along with technical data analysis and alternative data insights.
Does AURA offer dividends to its shareholders?
As of our latest update, Aura Biosciences (AURA) does not offer dividends to its shareholders. Investors interested in Aura Biosciences should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Aura Biosciences?
Some of the similar stocks of Aura Biosciences are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.